Alan A. Rivera

FDA investigator · also recorded as Geri Alan A. Rivera, Ee Alan A. Rivera

Appears on 16 documents from 2022 to 2026, mostly at sites in India. Most often cites general requirements (21 CFR 211.160).

16
Documents on file
4.9
Observations per 483
2022
First seen
2026
Most recent

What they cite most

From 74 observations

Activity by year

2022: 1, 2023: 3, 2024: 6, 2025: 4, 2026: 2

Where

India 9 · Puerto Rico 4 · China 3

Is Alan A. Rivera coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

16 documents, newest first
FirmOpen
483 Maiva Pharma Private LimitedFeb 20, 2026 · Hosur, India
483 Global Calcium Pvt. LimitedFeb 3, 2026 · Tamil Nadu, India
483 Gland Chemicals Private LimitedNov 27, 2025 · Chennai, India
483 ONESOURCE SPECIALTY PHARMA LIMITEDMar 28, 2025 · Doddaballapura, India
483 Amneal Pharmaceuticals Private LimitedMar 19, 2025 · Mehsana, India
483 Gland Chemicals Private Limited B-11 Plot No B-3, Sipcot Industrial Park & B-6 to B-18Jan 27, 2025 · Chennai, India
483 Zhejiang Tianyu Pharmaceutical Co., Ltd.Nov 29, 2024 · Taizhou, China

About this profile

What does Alan A. Rivera inspect?

Alan A. Rivera appears on 16 documents on file covering 15 sites, mostly in India.

What do they cite most often?

21 CFR 211.160 (general requirements), followed by 21 CFR 211.113 and 21 CFR 211.42.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Alan A. Rivera is dated Feb 20, 2026.